86 search results for: mechanism of disease

TBD
Dermatology
Prurigo Nodularis (PN): Understanding Its Clinical Features, Complex Burden, and Underlying Mechanisms
Infographic

Explore the clinical features, complex burden, and underlying mechanisms of PN.

View more
ERS 2024 | Unraveling the Role <b>of</b> Type 2 Inflammation in COPD
Pulmonology
ERS 2024 | Unraveling the Role of Type 2 Inflammation in COPD
expert video

Professor Mona Bafadhel presents a comprehensive overview of type 2 inflammation in COPD, exploring its underlying mechanisms, clinical manifestations, and implications for patient outcomes.

View more
ERS 2024 | Understanding the Complex Pathophysiology <b>of</b> COPD
Pulmonology
ERS 2024 | Understanding the Complex Pathophysiology of COPD
expert video

Professor Klaus Rabe delves into the intricate inflammatory pathways and cellular mechanisms that drive the development and progression of COPD.

View more
ERS 2024 | The Role <b>of</b> IL-33 in COPD Patho and Its Impact on <b>Disease</b> Remodeling
Pulmonology
ERS 2024 | The Role of IL-33 in COPD Patho and Its Impact on Disease Remodeling
expert video

Professor Paola Rogliani examines the role of IL-33 in the pathophysiology of COPD, focusing on its contribution to airway inflammation, remodeling, and disease progression.

View more
The Role <b>of</b> Type 2 Inflammation in Multiple <b>Disease</b> Trajectories
Dermatology
The Role of Type 2 Inflammation in Multiple Disease Trajectories
Infographic

How type 2 inflammation drives atopic dermatitis and underlies other atopic diseases across multiple disease trajectories including the atopic march.

View more
ADVENT at ATS 2026
On Demand
ADVENT at ATS 2026

At ATS 2026, the Sanofi & Regeneron ADVENT Booth brings together interactive experiences and educational resources to explore Type 2 inflammation as a key feature underlying both asthma and COPD.​

Pathways to <b>Disease</b>: Inflammation in COPD
Pulmonology
Pathways to Disease: Inflammation in COPD
interactivity

Learn about the pathophysiology of COPD and the involvement of chronic inflammation on the airways

View more
COPD and Asthma: What's the Difference and Is There a Link?
Pulmonology
COPD and Asthma: What's the Difference and Is There a Link?
interactivity

Explore the characteristics of COPD and asthma, focusing on their shared inflammatory mechanisms and key clinical differences.

View more
EAPS
On Demand
Emerging Perspectives on the Disease Burden and Management of Children with Atopic Dermatitis

Join Christine Bangert, Mark Boguniewicz and Perla Lansang for an educational symposium on atopic dermatitis (AD) in children, exploring the diagnosis and pathophysiology of AD in children, the life-long effects of uncontrolled disease beyond the skin, and current and emerging therapies.

ADVENT Dermatology Symposium in Denver, CO
On Demand
Cracking the Code: Diagnosing and Managing Skin Diseases With Type 2 Inflammation​

This 2-hour educational program delves into the pivotal role of type 2 inflammation in diverse skin conditions, including atopic dermatitis, prurigo nodularis, bullous pemphigoid, and chronic spontaneous urticaria. It will highlight both shared and distinct disease mechanisms and patient burdens, providing crucial insights for optimizing clinical management strategies. Experts will guide the audience through diverse patient cases to illuminate diagnostic nuances and the pathophysiology of each condition. These cases will also highlight the importance of shared decision-making and the broadening of treatment goals beyond symptom control. Dynamic panel discussion and active audience participation will be facilitated through real-time polling and curated Q&A sessions.

thumbnail
Congress
17
May
2026
Congress
ADVENT at ATS 2026

At ATS 2026, the Sanofi & Regeneron ADVENT Booth #1301 brings together interactive experiences and educational resources to explore Type 2 inflammation as a key feature underlying both asthma and COPD.​

Event Page Thumbnail
Congress
27
April
2026
Congress
ADVENT at CEORL-HNS 2026

Join Sanofi and Regeneron for an educational symposium on type 2 inflammation, patient characteristics predictive of disease recurrence, and emerging real-world evidence for biologics in CRSwNP.